Pharmaceutical giant Pfizer Inc. said Wednesday that it plans to apply for emergency use authorization in the United States for a potential COVID-19 vaccine “within days,” as it has shown the vaccine to be effective in clinical study.The two-dose vaccine, jointly developed with German firm BioNTech SE, met “all of the study’s primary efficacy endpoints,” the companies said in their press release, noting that an analysis indicated the vaccine was 95 percent effective in preventing the disease caused by the novel coronavirus.Last week, the companies released an interim analysis from the phase-th…
- Trump Could Face Prison Time In Georgia - January 18, 2021
- Heavily armed man arrested at Washington security checkpoint - January 16, 2021
- Rev. Franklin Graham Compares Trump To Jesus, Calls Republicans Who Voted For Impeachment Traitors - January 15, 2021
- Trump Could Pose Flight Risk After Jan. 20 If He’s Charged For Inciting Capitol Riots - January 14, 2021
- US Justice Dept expects sedition, conspiracy cases in Capitol attack - January 12, 2021
- Far-right groups planning ‘armed protests’ across US before Biden’s inauguration, FBI says - January 11, 2021
- Impeachment – First Amendment May Not Protect Trump - January 11, 2021
- Fresh calls for Trump to resign after Capitol violence - January 10, 2021
- Trump backer seen in horned fur hat charged in Capitol violence - January 9, 2021
- Pelosi says spoke with military chief on preventing Trump nuclear strike - January 8, 2021
